Centessa Pharmaceuticals plc (CNTA)

NASDAQ: CNTA · IEX Real-Time Price · USD

9.55

+0.07 (0.74%)

At close: May 2, 2024, 4:00 PM

9.46

-0.09 (-0.94%)

After-hours: May 2, 2024, 7:12 PM EDT

Centessa Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-151.09	-216.21	-381.07	-10.66	5.06
Depreciation & Amortization	0.81	0.13	0.03	0	0.01
Share-Based Compensation	29.39	24.97	14.85	0.34	0.24
Other Operating Activities	-39.46	-9.44	231.08	-0.3	-11.13
Operating Cash Flow	-160.34	-200.55	-135.11	-10.63	-5.83
Capital Expenditures	-0.17	-1.14	-0.19	0	0
Acquisitions	0	0	63.44	0	0
Change in Investments	-126.84	0	0	0	0
Other Investing Activities	-	0.21	-	-	-
Investing Cash Flow	-127	-0.93	63.26	0	0
Share Issuance / Repurchase	21.12	0.72	344.92	0	0.01
Debt Issued / Paid	0	0	73.93	1.36	3.83
Other Financing Activities	-	-0.26	241.3	-	5.17
Financing Cash Flow	21.12	0.46	660.15	1.36	9.01
Exchange Rate Effect	0.62	-0.42	1.82	-0.08	0.52
Net Cash Flow	-265.61	-201.44	590.12	-9.34	3.7
Free Cash Flow	-160.51	-201.68	-135.3	-10.63	-5.83
Free Cash Flow Margin	-2342.20%	-	-	-	-
Free Cash Flow Per Share	-1.67	-2.16	-1.80	-0.12	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).